CLINICAL SIGNIFICANCE OF CELLULAR EXPRESSION OF KL-6 MUCIN IN CHOLANGIOCRCINOMA
CLINICAL SIGNIFICANCE OF CELLULAR EXPRESSION OF KL-6 MUCIN IN CHOLANGIOCRCINOMA
批准号:
17591379
负责人:
KARAKO Takashi
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006
中文摘要
胆管癌(CC)患者的预后比肝细胞癌(HCC)患者尤其差,这是由于许多病例中胆管癌的诊断困难。因此,寻找一种有效的肿瘤标志物对CC进行早期诊断和预后评估具有重要意义。在本研究中,我们旨在通过免疫组织化学和血清学分析阐明KL-6粘蛋白在CC患者中的意义。组织化学分析显示,仅在CC组织中检测到KL-6粘蛋白阳性染色,而在所有肝癌组织的HCC组织和正常肝区均未检测到KL-6粘蛋白阳性染色。血清学分析显示,与健康人、HCC患者和转移性肝癌患者相比,CC患者血清KL-6粘蛋白水平升高(P<0.0001),并可将临界值设置为248 U/mL与其他肝癌患者区分。提示KL-6粘蛋白可用于CC患者的组织化学检测和血清学鉴别。此外,转移性肝癌组织的免疫组化分析显示,所有组织均阳性表达KL-6粘蛋白,但KL-6的表达特征与CC组织不同,血清中KL-6粘蛋白水平也不同。此外,对多种结肠癌细胞系的实验表明,KL-6粘蛋白的定位与癌细胞形态和转移潜能等癌症行为有显著关系。本研究表明,KL-6是CC诊断和阐明各种胃肠道肿瘤行为的前瞻性工具。
英文摘要
Patients with cholangiocarcinoma (CC) has particularly worse prognosis than those with hepatocellular carcinoma (HCC), which is due to the difficulty of the diagnosis of CC in many cases. Thus, it is important to develop an effective tumor marker that can diagnosis CC in early phase and estimate patients' prognosis. In this study, we aimed to elucidate significance of KL-6 mucin in CC patients by immunohistochemical and seralogical analyses. The histochemical analysis showed that positive staining of KL-6 mucin was detected only in CC tissues but not in HCC tissues and normal liver regions of all liver cancer tissues. Serological analysis showed serum KL-6 mucin level was elevated in CC patients compared with healthy individuals, HCC patients and metastatic liver cancer patients (P<0.0001) and that CC patients were able to be discrminate from other liver cancer patients by setting a cut-off value at 248 U/mL. These results indicated that KL-6 mucin might be useful in the histochemical detection and serological discrimination of CC patients. Furthermore, the immunohistochemical analysis of metastatic liver cancer tissues displayed that all tissues were positive for KL-6 mucin, but the characteristics of KL-6 expression is not the same as CC tissues as well as serum KL-6 mucin level. Moreover, experiment using various kinds of colon cancer lines showed that the localization of KL-6 mucin was significantly related to the cancer behavior such as cancer cell morphology and metastatic potential. The present study indicates that KL-6 is prospective tool for CC diagnosis and elucidation of various gastrointestinal cancer behaviors.
期刊论文(34)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Simultaneous resection of liver cell adenomas and an intrahepatic portosystemic venous shunt with elevation of serum PIVKA-II level.
同时切除肝细胞腺瘤和肝内门体静脉分流术,血清 PIVKA-II 水平升高。
DOI:
--
发表时间:
2006
期刊:
J Gastroenterol 41(9)
影响因子:
--
作者:
[諸角誠人, 小川由英, 他, 大神一浩, Seyama Y]
通讯作者:
Seyama Y
Clinical significance of subcellular lacalization of KL-6 mucin in primary colorectal adenocarcinoma and metastatic tissues.
原发性结直肠腺癌和转移组织中KL-6粘蛋白亚细胞定位的临床意义。
DOI:
--
发表时间:
2006
期刊:
World J Gastroenterol 12(1)
影响因子:
--
作者:
[Guo Q, TANG W, 他2名, Kokudo N, 他4名, Makuuchi M]
通讯作者:
Makuuchi M
DOI:
--
发表时间:
2009-01
期刊:
Hepato-gastroenterology
影响因子:
--
作者:
[Keming Zhang;Wei Tang;Xian-Jun Qu;Q. Guo;Y. Inagaki;Y. Seyama;H. Abe;R. Gai;N. Kokudo;Y. Sugawara;M. Nakata;M. Makuuchi]
通讯作者:
Keming Zhang;Wei Tang;Xian-Jun Qu;Q. Guo;Y. Inagaki;Y. Seyama;H. Abe;R. Gai;N. Kokudo;Y. Sugawara;M. Nakata;M. Makuuchi
Detection of new tumors by intraoperative ultrasonography during repeated hepatic resections for hepatocellular carcinoma.
在肝细胞癌的重复肝切除过程中通过术中超声检测新肿瘤。
DOI:
--
发表时间:
2007
期刊:
Arch Surg 142
影响因子:
--
作者:
[Zhang K, Kokudo N, Hasegawa K, Arita J, Tang W, Aoki T, Imamura H, Sano K, Sugawara Y, Makuuchi M.]
通讯作者:
Makuuchi M.
Epidermal growth factor-mediated growth control of confluent mammary epithelial cells cultured on artificial basement membrane
表皮生长因子介导的人工基底膜上培养的汇合乳腺上皮细胞的生长控制
DOI:
--
发表时间:
2005
期刊:
Int J Mol Med 16(3)
影响因子:
--
作者:
[Guo Q, TANG W, 他5名, Nakata M, Fujita-Yamaguchi Y, Makuuchi M]
通讯作者:
Makuuchi M
共 14 条
Development of novel molecular-targeted medicine against aminopeptidase
-
批准号:21390373
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.15万
-
财政年份:2009
-
负责人:KARAKO Takashi
-
依托单位:
Inhibition of intrahepatic metastasis of hepatocellularcarcinoma by novel pyrrolidine derivatives
-
批准号:19591578
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2007
-
负责人:KARAKO Takashi
-
依托单位:
ASSOCIATION OF GLYCOCONJUGATES EXPRESSION AND CLINICAL SIGNIFICANCE IN PATIENTS WITH METASTATIC CANCER OF THE LIVER
-
批准号:15591384
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2003
-
负责人:KARAKO Takashi
-
依托单位:
ASSOCIATION OF GLYCOCONJUGA.TES EXPRESSION APjO) CUNICAL SIGNIFICANCE IN HUMAN GASTRIC CANCER
-
批准号:13671286
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2001
-
负责人:KARAKO Takashi
-
依托单位:
海外基金